Platinum Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
Other funds holding AERI
PHS
LCS
FAM
RHJA
Platinum Investment Management's AERI Position: Q2 2020 in Review
Platinum Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2020, closing a stake of 113,842 shares — an estimated $1.54M sold.
Platinum Investment Management first reported a position in AERI in Q3 2014 and held it in 23 quarters. The position peaked at $2.98M in Q3 2016. 155 funds tracked by Wall St. Rank hold AERI as of Q2 2020.
- Platinum Investment Management reported no remaining Aerie Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
- Platinum Investment Management sold 113,842 Aerie Pharmaceuticals shares in Q2 2020, an estimated $1.54M.
- Platinum Investment Management first reported a position in Aerie Pharmaceuticals in Q3 2014 and held it in 23 quarters.
- Platinum Investment Management's Aerie Pharmaceuticals position peaked at $2.98M in Q3 2016.
- 155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2020.
Based on Platinum Investment Management's 13F filing for Q2 2020, filed 6 Aug 2020.